StockTipsArenaBeta

BUY Laurus Labs Ltd — Shivangi Sarda, Motilal Oswal

BUYLaurus Labs Ltd
Laurus Labs share price target & all analyst calls

byShivangi Sarda, Motilal OswalHorizon: NA (inferred Intraday)28 Jul 2026, 9:32 am ISTvia CNBC Awaaz.

Entry₹1,730.3Inferred
Target₹1,770
Total upside +2.29% (call closed)
Stop loss₹1,680-2.91% risk
At expiry₹1,760.628 Jul 2026, 3:20 pm
Expired+1.75%
Follow Shivangi Sarda for new calls(12% target hit, 26 closed calls)Get alertsWatch LAURUSLABS for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Jul 2026
6 supporting7 neutral0 opposing
Supports the BUY call (6)

10% Returns In Five Days: This Pharma Stock Hits Record High After Q1 Results

NewsNdtv-Profit·28 Jul · today

(opens in new tab)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·28 Jul · today

Laurus Labs shares hit record high after multiple upgrades, but Kotak still sees 33% downside

NewsCnbc-Tv18·27 Jul · yesterday

(opens in new tab)

Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth

NewsEt-Markets·27 Jul · yesterday

(opens in new tab)

Laurus Labs Q1 Results: Stock jumps after margins cross 30%, other parameters beat

NewsCnbc-Tv18·24 Jul · 4d ago

(opens in new tab)
Neutral / worth noting (7)

Nifty in oversold territory; pullback to 24,000 possible: Analysts

NewsEt-Markets·27 Jul · yesterday

(opens in new tab)

Laurus Labs Limited has disclosed information regarding a composite scheme of arrangement involving its subsidiaries, Laurus Synthesis Private Limited and Sriam Labs Private Limited. The National Comp

BSE · Company Update·25 Jul · 2d ago

(opens in new tab)

Q1 Results Today Highlights: Tata Consumer con. PAT up 28.4%, ACC PAT declines 61.5%, Shriram Finance, Hindustan Zinc, SBI Life, SBI Cards, Laurus Labs Q1 profit rise

NewsHbl·24 Jul · 4d ago

(opens in new tab)

Laurus Labs Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The press release is enclosed for information.

BSE · Company Update·24 Jul · 4d ago

(opens in new tab)

Laurus Labs Ltd announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved at a Board Meeting held on July 24,

BSE · Board Meeting·24 Jul · 4d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Laurus Labs

All analyst calls on Laurus Labs

More from Shivangi Sarda, Motilal Oswal

Every call and its outcome